Delete search term

Header

Main navigation

Development of therapeutic mAb and ADCs

Description

For the early stage development of monoclonal therapeutic antibodies and antibody-drug conjugates (ADC), lead candidates are thoroughly probed employing a broad portfolio of bioanalytical methods. Therein, molecules are additionally exposed to various stress conditions to determine their robustness and to select the most stable candidates.

Key Data

Project status

completed, 03/2021 - 12/2022

Funding partner

Third party